Delivery Order SPE2DB22D3009-SPE2DB25FAH36
- Not listed
- This federal contract award, with ID SPE2DB24D3015|SPE2DB25FFWVQ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product, with an ultimate completion date of October 30, 2024 and a ceiling value of $20,630.92. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated...
- This federal contract award, with a value of $26,803.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for TALTZ 80 MG/ML AUTOINJECTOR, a pharmaceutical product, with a performance period through December 15, 2023. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,037.80, is a delivery order for the supply of TALTZ 80 MG/ML AUTOINJ (3-PK)ML, a pharmaceutical product. The contract has an ultimate completion date of October 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALTZ 80 MG/ML AUTOINJ (2-PK)ML, a pharmaceutical product. The contract has a ceiling value of $45,587.65 and is a firm fixed price contract with a completion date of July 16, 2025. The contract is not set aside and is open to competition. AmerisourceBergen Drug Corp, the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $33,279.90, is a delivery order for the supply of TALTZ 80 MG/ML AUTOINJ (2-PK)ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 6, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
- This federal contract award, valued at $50,324.34, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of TALTZ 80 MG/ML AUTOINJ (2-PK)ML, a pharmaceutical product, with a period of performance through October 9, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and...
- This federal contract award, valued at $4,570.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product, and has an ultimate completion date of January 9, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....
- This federal contract award, valued at $10,622.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of 4,565,825,517 units of TALTZ 80 MG/ML AUTOINJ (2-PK)ML, a pharmaceutical product. The contract has an ultimate completion date of September 17, 2024 and is a Firm Fixed Price Delivery Order. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical...
- The federal contract award, with ID SPE2DB22D2214|SPE2DB25FS4AH, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,000.49, is a Firm Fixed Price Delivery Order for the supply of TALTZ 80 MG/ML AUTOINJECTOR ML, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. Amerisourcebergen Drug Corp is a for-profit organization and a...
- This is a federal contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALTZ 80 MG/ML AUTOINJ (2-PK)ML, a pharmaceutical product. The contract has a ceiling value of $9,470.02 and is a firm fixed-price delivery order contract with a period of performance through June 24, 2025. The contract is not set aside for any specific business type....
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FAH36Delivery Order
This federal contract award, with the ID SPE2DB22D3009|SPE2DB25FAH36, was granted by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of 4566251422 ! TALTZ 80 MG/ML AUTOINJ (2-PK)ML, a pharmaceutical product, with a ceiling value of $24,918.58. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is October 29, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the military and veterans' healthcare systems. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.9k | 10/28/24 |